NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding NextCure, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 26 | 30 | +4 |
| Shares | 2.17M | 1.74M | −434.3K (−20.0%) |
| Value | $23.0M | $2.78M | −$20.2M (−87.9%) |
New holders (11)
Institutions that held NextCure, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Adage Capital Partners GP, L.L.C. | 277,202 | $443.5K | 0.00% |
| Millennium Management LLC | 88,112 | $141.0K | 0.00% |
| HRT Financial LP | 36,450 | $58.0K | 0.00% |
| Jane Street Group, LLC | 32,725 | $52.4K | 0.00% |
| Nomura Asset Management International Inc. | 12,500 | $20.0K | 0.00% |
| Virtu Financial LLC | 10,991 | $18.0K | 0.00% |
| Diadema Partners LP | 7,742 | $12.4K | 0.00% |
| Persistent Asset Partners Ltd | 1,981 | $3.17K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,738 | $2.78K | 0.00% |
| Northwestern Mutual Wealth Management Co | 83 | $133 | 0.00% |
| SBI Securities Co., Ltd. | 20 | $32 | 0.00% |
Sold out (7)
Institutions that held NextCure, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Silverarc Capital Management, LLC | 176,057 | $1.88M |
| Opaleye Management Inc. | 141,181 | $1.51M |
| AWM Investment Company, Inc. | 117,371 | $1.23M |
| Exome Asset Management LLC | 115,500 | $1.22M |
| Woodline Partners LP | 27,498 | $293.7K |
| Citadel Advisors LLC | 15,292 | $160.9K |
| Citigroup Inc | 1 | $11 |